EP2330124
Hybrid polypeptides with selectable properties
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.8.2006EP published:
25.2.2015EP application number:
10012149.0
EPO information:
European Patent Register
Max expiry date:
10.8.2026
Title:
Hybrid polypeptides with selectable properties
Timeline
Today
11.8.2006EP application
25.2.2015EP Publication
Owner
Name:
Amylin Pharmaceuticals, LLCAddress:
9360 Towne Centre Drive, 92121, San Diego, CA, US
Name:
AstraZeneca Pharmaceuticals LPAddress:
1800 Concord Pike, Wilmington, DE, US
Inventor
Name:
Levy, Odile EstherAddress:
San Diego, CA, US
Name:
Hanley, Michael R.Address:
San Diego, CA, US
Name:
Jodka, Carolyn M.Address:
San Diego, CA, US
Name:
Lewis, DianaAddress:
San Diego, CA, US
Name:
Soares, Christopher J.Address:
San Diego, CA, US
Name:
Ghosh, Soumitra S.Address:
San Diego, CA, US
Name:
D'Souza, LawrenceAddress:
San Diego, CA, US
Name:
Parkes, David G.Address:
San Diego, CA, US
Name:
Mack, Christine M.Address:
San Diego, CA, US
Name:
Forood, Behrouz BruceAddress:
San Diego, CA, US
Priority
Number:
201664Date:
11.8.2005Country:
US
Number:
206903Date:
17.8.2005Country:
US
Number:
301744Date:
12.12.2005Country:
US
Classification
Categories:
C07K 14/575, A61K 38/00